Device Trial Radar · NCT02102464
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers
Last checked: Nov 19, 2026Latest source record: Oct 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
55
Actual
Start
Apr 2014
Primary completion
Aug 2015
Study completion Sep 2015
Sponsor
- Lead sponsor
- TearScience, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 3, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The pilot study objective is to evaluate the potential benefits of LipiFlow® System treatment of contact lens wearers with meibomian gland dysfunction and evaporative dry eye by assessing for improvement in meibomian gland function and reduction of dry eye symptoms in comparison to an untreated control.
Conditions
- Meibomian Gland Dysfunction
- Dry Eye
Interventions
LipiFlow treatmentDevice
The LipiFlow® Thermal Pulsation System is a prescription device intended for the application of localized heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change in Meibomian Gland Score From Baseline at 3 MonthsTime frame: 3 Months
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
School of Optometry, The University of Alabama at Birmingham
Birmingham, Alabama
Clayton Eye Center
Morrow, Georgia
Charlotte Eye Ear Nose and Throat Associates, P.A.
Charlotte, North Carolina
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.